No Pain More Gain

Description

NPMG Foam is a topical formulation designed for application to the skin. It is characterized by its foam dosage form, which facilitates ease of application and absorption. The product is intended for use in specific dermatological conditions, providing targeted treatment through its active ingredients. The formulation is designed to deliver therapeutic benefits while ensuring patient comfort during use.

Uses and Indications

This drug is indicated for the treatment of pain and as a preventive measure for sensitive areas. It provides temporary yet long-lasting pain relief while also moisturizing the skin. Formulated with an advanced German formula, this natural alternative begins to take effect upon contact, penetrating deeply and absorbing quickly. The product is characterized by a fresh and pleasant scent.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should instruct patients to shake the product well before use. For adults and children aged 2 years and older, the recommended application is to the affected areas up to four times daily. It is important to massage the product gently into the skin to ensure proper absorption and effectiveness.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to discontinue use and consult a healthcare professional if any of the following occur: worsening of the condition, skin irritation, or if symptoms persist for more than 7 days or resolve and then recur within a few days.

Warnings and Precautions

For external use only, this product should be applied with caution to avoid contact with the eyes and mucous membranes. It is imperative that the product not be used in conjunction with a heating pad, as this may lead to adverse effects. Additionally, the application of this product on open wounds or broken skin is contraindicated.

Healthcare professionals should advise patients to discontinue use and consult a physician if any of the following occur: worsening of the condition, development of skin irritation, or if symptoms persist for more than 7 days. Patients should also be instructed to seek medical advice if symptoms resolve and then recur within a few days.

While no specific emergency medical instructions are provided, it is essential for healthcare providers to remain vigilant and prepared to address any unexpected reactions or complications that may arise during treatment.

Currently, there are no specific laboratory tests recommended for monitoring the use of this product. However, healthcare professionals should remain attentive to the patient's overall condition and any potential side effects that may necessitate further evaluation.

Side Effects

Patients should be aware that the product is intended for external use only. It is crucial to avoid contact with the eyes and mucous membranes, as this may lead to adverse effects. Additionally, the product should not be used in conjunction with a heating pad, nor should it be applied to open wounds or broken skin.

In the event that the condition worsens, skin irritation occurs, or symptoms persist for more than 7 days, or clear up and then recur within a few days, patients are advised to stop use and consult a healthcare professional. These precautions are essential to ensure the safe and effective use of the product.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions between the drug and laboratory tests. As such, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of No Pain More Gain (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older may apply the medication to the affected areas up to four times daily. There are no specific dosage adjustments indicated for this age group. Care should be taken to monitor for any adverse reactions during treatment.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this product in pregnant patients. The prescribing information does not indicate whether the product is contraindicated during pregnancy or outline any associated risks to the fetus. Additionally, there are no dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of detailed guidance necessitates careful clinical judgment and individualized patient assessment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include airway management, monitoring of vital signs, and intravenous fluid administration as necessary. The use of specific antidotes or treatments should be guided by the clinical scenario and the substances involved.

For further management, consultation with a poison control center or a medical toxicologist is recommended to ensure appropriate therapeutic interventions are implemented. Documentation of the incident and any interventions performed is crucial for ongoing patient care and safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion.

Patients should be instructed to stop using the product and consult a doctor if any of the following occur: the condition worsens, skin irritation develops, or if symptoms persist for more than 7 days. Additionally, patients should be informed to seek medical advice if symptoms clear up and then recur within a few days. This guidance is essential to ensure patient safety and effective management of their condition.

Storage and Handling

The product is supplied in containers that are under pressure. It is essential to store the product in a cool, dry place, away from direct sunlight and any sources of ignition. The storage temperature must not exceed 120°F.

Care should be taken to avoid exposing the container to flames or hot surfaces. Additionally, the container should not be punctured or incinerated, as this may pose safety risks. Proper handling and storage conditions are crucial to ensure the integrity and safety of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for No Pain More Gain, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)